Patent
   D377686
Priority
Mar 25 1994
Filed
Sep 26 1994
Issued
Jan 28 1997
Expiry
Jan 28 2011
Assg.orig
Entity
unknown
53
14
n/a
The ornamental design for a training device for inhaler, as shown.

FIG. 1 is a front perspective view of the training device for an inhaler, the inhaler being shown with the protective cap removed;

FIG. 2 is a view of the front of the box portion of the training device, which has been enlarged for ease of illustration;

FIG. 3 is a back view of the box portion of the training device shown in FIG. 2;

FIG. 4 is a left side view of the box portion of the training device shown in FIG. 2;

FIG. 5 is a right side view of the box portion of the training device shown in FIG. 2;

FIG. 6 is a top view of the box portion of the training device shown in FIG. 2;

FIG. 7 is a bottom view of the box portion of the training device shown in FIG. 2;

FIG. 8 is a side view of the inhaler portion of the training device shown in FIG. 1, which has been enlarged for ease of illustration;

FIG. 9 is another side view of the inhaler portion of the training device shown in FIG. 8;

FIG. 10 is another side elevational view of the inhaler portion of the training device shown in FIG. 8;

FIG. 11 is another side view of the inhaler portion of the training device shown in FIG. 8;

FIG. 12 is a top view of the inhaler portion of the training device shown in FIG. 1 with the protective cap removed, which has been enlarged for ease of illustration;

FIG. 13 is a bottom view of the inhaler portion of the training device shown in FIG. 12; and,

FIG. 14 is a side view of the protective cap shown in FIG. 1, which has been enlarged for ease of illustration.

Waldeck, Johan, Marnfeldt, Nils G.

Patent Priority Assignee Title
10130581, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
10130685, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
10130709, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
10143655, Sep 14 2005 MannKind Corporation Method of drug formulation
10159644, Oct 26 2012 MannKind Corporation; TechnoVax, Inc. Inhalable vaccine compositions and methods
10172850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
10201672, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
10258664, Oct 24 2011 MannKind Corporation Methods and compositions for treating pain
10307464, Mar 27 2015 MannKind Corporation Use of ultrarapid acting insulin
10342938, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
10421729, Mar 15 2013 MannKind Corporation Microcrystalline diketopiperazine compositions and methods
10561806, Oct 02 2014 MannKind Corporation Mouthpiece cover for an inhaler
10625034, Apr 01 2011 MannKind Corporation Blister package for pharmaceutical cartridges
10675421, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
10751488, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
11446127, Aug 05 2013 MannKind Corporation Insufflation apparatus and methods
11478591, May 19 2016 MannKind Corporation Apparatus, system and method for detecting and monitoring inhalations
8424518, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8485180, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
8499757, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8636001, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
8912193, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9192675, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9220687, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9233159, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9241903, Feb 22 2006 MannKind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
9283193, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9339615, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9358352, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9364436, Jun 17 2011 MannKind Corporation High capacity diketopiperazine microparticles and methods
9364619, Jun 20 2008 MannKind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
9393372, Jun 13 2008 MannKind Corporation Dry powder drug delivery system
9446001, Sep 14 2005 MannKind Corporation Increasing drug affinity for crystalline microparticle surfaces
9446133, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9511198, Jun 13 2008 MannKind Corporation Dry powder inhaler and system for drug delivery
9610351, Oct 24 2011 MannKind Corporation; Torrey Pines Institute for Molecular Studies Methods and compositions for treating pain
9630930, Jun 12 2009 MannKind Corporation Diketopiperazine microparticles with defined specific surface areas
9655850, Dec 29 2008 MannKind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
9662461, Jun 13 2008 MannKind Corporation Dry powder drug delivery system and methods
9675674, Aug 23 2004 MannKind Corporation Diketopiperazine salts for drug delivery and related methods
9700690, Mar 20 2002 MannKind Corporation Inhalation apparatus
9706944, Nov 03 2009 MannKind Corporation Apparatus and method for simulating inhalation efforts
9717689, Sep 14 2005 MannKind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
9796688, Aug 20 2004 MannKind Corporation Catalysis of diketopiperazine synthesis
9801925, Jun 29 1999 MannKind Corporation Potentiation of glucose elimination
9802012, Jul 12 2012 MannKind Corporation Dry powder drug delivery system and methods
9925144, Jul 18 2013 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
9943571, Aug 11 2008 MannKind Corporation Use of ultrarapid acting insulin
9983108, Mar 11 2009 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
D417732, Mar 30 1998 Astra Aktiebolag Dry powder inhaler with cover
D417912, Mar 30 1998 Astra Aktiebolag Dry powder inhaler with cover
D441446, Mar 30 1998 Astra Aktiebolag Dry powder inhaler with cover
D450381, Dec 15 2000 SMITHS MEDICAL ASD, INC Maximum expiratory pressure and cough simulation device
Patent Priority Assignee Title
4524769, Jul 08 1981 Aktiebolaget Draco Dosage inhalator
4534345, Jul 08 1981 Aktiebolaget Draco Dosage inhalator
4668218, Apr 12 1985 AstraZeneca AB Indicating means for a dosage dispensing device
4907583, Mar 07 1986 AstraZeneca AB Device in powder inhalators
4984158, Oct 14 1988 SIERRA BIOTECHNOLOGY COMPANY, L C Metered dose inhaler biofeedback training and evaluation system
5019974, May 01 1987 EURUS LLC; DIVA MEDICAL MANAGEMENT SYSTEMS BY Diabetes management system and apparatus
5024219, Jan 12 1987 Apparatus for inhalation therapy using triggered dose oxygenator employing an optoelectronic inhalation sensor
5331953, Mar 07 1989 Aktiebolaget Draco Device in connection with an inhaler
5404871, Mar 05 1991 Aradigm Corporation Delivery of aerosol medications for inspiration
5431154, Nov 29 1991 Incentive metered dose inhaler
D348928, Sep 21 1992 Schering Corporation Inhaler
D362500, Jun 28 1994 THAYER MEDICAL CORPORATION Medication inhaler spacer
WO9010470,
WO9321980,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Sep 26 1994Astra Aktiebolag(assignment on the face of the patent)
Dec 19 1994WALDECK, JOHANAstra AktiebolagASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0073230847 pdf
Dec 19 1994MARNFELDT, NILS GORANAstra AktiebolagASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0073230847 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule